CHEMICAL AND PHYSICAL PROPERTIES
| Solubility | Water > 10.12 (mg/mL) |
|---|---|
| Stability/Shelf Life | Bulk: Test samples stored for 3 months at 25 °C and 50 °C under light and dark conditions showed no degradation (HPLC). Solution: Aqueous solutions 2 mg/mL) showed no degradation after 48 hr at 25 °C. |
COMPUTED DESCRIPTORS
| Molecular Weight | 367.4 g/mol |
|---|---|
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 367.16443955 g/mol |
| Monoisotopic Mass | 367.16443955 g/mol |
| Topological Polar Surface Area | 88.1 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 542 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Pyrazoloacridine has been used in trials studying the treatment of Lung Cancer, Liver Cancer, Breast Cancer, Melanoma (Skin), and Metastatic Cancer, among others.